BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 11, 2000
View Archived Issues
Testosterone buccal tablet enters late-stage clinical testing
Read More
Dimethaid receives approval for Pennsaid lotion in U.K.
Read More
Oxford GlycoSciences and Glaxo Wellcome enter proteomics alliance
Read More
Neurochem demonstrates proof of concept for AD compound
Read More
Immunosuppressive drug in development at Isotechnika shows promise in phase I
Read More
Biogen licenses novel neurotrophic protein from NsGene
Read More
BMS extends license for PathoGenome database
Read More
Viventia Biotech's H11 enters phase I/II oncology trial
Read More
ARANESP effective given once weekly, and possibly less frequently, in treating anemia
Read More
Early clinical evidence of efficacy, safety of UCN-01 plus fludarabine phosphate in CLL
Read More
Gilead obtains rights to Glaxo Wellcome TS inhibitor
Read More
Apomate imaging agent receives orphan drug status from FDA
Read More
ASH news: proteasome inhibitor LDP-341 as attractive new drug for multiple myeloma, CLL
Read More
Heparin inhibition of complement activation: comparative effects of Neutralase and protamine
Read More
Synaptic discovers peptide ligand that potentially inhibits metastasis
Read More
FDA approves Protopic for the treatment of eczema
Read More
New combretastatin prodrug displays enhanced solubility and antitumor activity
Read More
Positive results for new glycopeptide show dramatic and sustained reductions in bacterial load
Read More
Myobloc is first FDA-approved treatment for cervical dystonia
Read More
Derivatives of 3-deoxy-desmycosin with antimicrobial activity designed by Pliva
Read More
New macrolides from Pliva exhibit broad spectrum of activity
Read More
Pyrazole-based antiinflammatory agents patented by Dr. Reddy's team
Read More
Nycomed Imaging identifies novel X-ray contrast agents
Read More
Inhibitors of Lp-PLA2 from SB reportedly useful for atherosclerosis
Read More
AstraZeneca presents new carboxypeptidase U inhibitors and use thereof
Read More
Highly selective dopamine D4 receptor partial agonists identified at German university
Read More
ConjuChem initiates phase I trial of novel analgesic product
Read More